JUST IN: Vaccine advisers to the FDA have voted unanimously to recommend emergency use authorization of a booster dose of Moderna's Covid-19 vaccine for certain groups
The FDA's Vaccines and Related Biological Products Advisory Committee agreed use of a booster dose would be safe and effective in some people six months out from their primary series.Moderna had asked for emergency use authorization for a half dose of its vaccine to be used as a booster for certain people.
The FDA's committee of independent advisers typically discusses and makes recommendations to the agency around vaccine authorizations and approvals, and the agency then makes the final decision about whether to OK a vaccine. If the FDA gives emergency use authorization to Moderna boosters, vaccine advisers to the US Centers for Disease Control and Prevention will meet to discuss which groups to recommend them to.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
FDA Staff Don’t Take Position on Moderna Covid-19 BoosterIn an unusual move, FDA staff didn't take a position on Moderna's application for a booster shot, indicating there may be insufficient data to support one
Consulte Mais informação »
FDA to take up Moderna, J&J Covid-19 booster questions this weekVaccine advisers to the FDA meet Thursday and Friday of this week to tackle the next round of questions about booster vaccines for Covid-19 — and they might be seeing the first trickle of data on mix-and-match boosters.
Consulte Mais informação »
COVID-19 Live Updates: FDA to hold crunch talks over J&J and Moderna vaccine boostersThe Food and Drug Administration is set to hold crucial meetings over the next two days to decide whether to issue booster shots of Johnson & Johnson and Moderna COVID vaccines. Follow Newsweek's liveblog for all the latest.
Consulte Mais informação »
Moderna has no plans to share its COVID-19 vaccine recipe, aims to increase production insteadModerna won't share the recipe for its COVID-19 vaccine because execs have concluded that scaling up the company’s own production is the best way to increase the global supply, the company’s chairman said.
Consulte Mais informação »
J&J Covid-19 Vaccine Recipients May Benefit More From Pfizer Or Moderna Boosters, Study FindsJ&J recipients who were administered Moderna or Pfizer boosters showed significantly higher antibody counts compared to those who received a booster of the same vaccine.
Consulte Mais informação »
White House's chief Covid-19 science officer calls on Moderna to 'step up' global vaccine effortsThe White House's top scientist focused on Covid-19 sought to ratchet up pressure on Moderna, saying the pharmaceutical giant needs to 'step up' to provide more of its Covid-19 vaccine to the world in the urgent race to get the pandemic under control.
Consulte Mais informação »